Skip to main content

Advertisement

SpringerLink
Log in

Understanding resistance in enterococcal infections

  • Understanding the Disease
  • Published:
Intensive Care Medicine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Abbreviations

BSI:

Bloodstream infections

CPK:

Creatine phosphokinase

ECOFF:

Epidemiological cut-off

EUCAST:

European Committee on Antimicrobial Susceptibility Testing

FDA:

Food and Drug Administration

HLAR:

High-level aminoglycoside resistance

IAI:

Intra-abdominal infection

ICU:

Intensive care unit

IE:

Infective endocarditis

LFTs:

Liver function tests

MIC:

Minimum inhibitory concentration

MDR:

Multidrug resistant

PCR:

Polymerase chain reaction

PBP:

Penicillin-binding protein

VRE:

Vancomycin-resistant entercococcus

References

  1. Tacconelli E, Carrara E, Savoldi A, Harbarth S, Mendelson M, Monnet DL, Pulcini C, Kahlmeter G, Kluytmans J, Carmeli Y, Ouellette M, Outterson K, Patel J, Cavaleri M, Cox EM, Houchens CR, Grayson ML, Hansen P, Singh N, Theuretzbacher U, Magrini N, WHO Pathogens Priority List Working Group (2018) Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis. Lancet Infect Dis 18(3):318–327

    Article  Google Scholar 

  2. Faron ML, Ledeboer NA, Buchan BW (2016) Resistance mechanisms, epidemiology, and approaches to screening for vancomycin-resistant enterococcus in the health care setting. J Clin Microbiol 54(10):2436–2447

    Article  CAS  Google Scholar 

  3. European Centre for Disease Prevention and Control (2018) European Center for Disease Prevention and Control. Surveillance of antimicrobial resistance in Europe 2017. http://ecdc.europa.eu/en/publications-data/surveillance-antimicrobial-resistance-europe-2017. Accessed 23 Sept 2019

  4. Bender JK, Cattoir V, Hegstad K, Sadowy E, Coque TM, Westh H, Hammerum AM, Schaffer K, Burns K, Murchan S, Novais C, Freitas AR, Peixe L, Del Grosso M, Pantosti A, Werner G (2018) Update on prevalence and mechanisms of resistance to linezolid, tigecycline and daptomycin in enterococci in Europe: towards a common nomenclature. Drug Resist Updat Rev Comment Antimicrob Anticancer Chemother 40:25–39

    Google Scholar 

  5. De Angelis G, Cataldo MA, De Waure C, Venturiello S, La Torre G, Cauda R, Carmeli Y, Tacconelli E (2014) Infection control and prevention measures to reduce the spread of vancomycin-resistant enterococci in hospitalized patients: a systematic review and meta-analysis. J Antimicrob Chemother 69(5):1185–1192

    Article  Google Scholar 

  6. Nigo M, Munita JM, Arias CA, Murray BE (2014) What’s new in the treatment of enterococcal endocarditis? Curr Infect Dis Rep 16(10):431

    Article  Google Scholar 

  7. Smith JR, Barber KE, Raut A, Aboutaleb M, Sakoulas G, Rybak MJ (2015) β-Lactam combinations with daptomycin provide synergy against vancomycin-resistant Enterococcus faecalis and Enterococcus faecium. J Antimicrob Chemother 70(6):1738–1743

    CAS  PubMed  PubMed Central  Google Scholar 

  8. Miller WR, Murray BE, Rice LB, Arias CA (2016) Vancomycin-resistant enterococci: therapeutic challenges in the 21st century. Infect Dis Clin N Am 30(2):415–439

    Article  Google Scholar 

  9. Mazuski JE, Tessier JM, May AK, Sawyer RG, Nadler EP, Rosengart MR, Chang PK, O’Neill PJ, Mollen KP, Huston JM, Diaz JJ Jr, Prince JM (2017) The surgical infection society revised guidelines on the management of intra-abdominal infection. Surg Infect 18(1):1–76

    Article  Google Scholar 

  10. Kanjilal S, Kalil AC, Klompas M (2018) What is the best treatment for vancomycin-resistant enterococcal bloodstream infections? Crit Care Med 46(10):1700–1703

    Article  Google Scholar 

  11. Shukla BS, Shelburne S, Reyes K, Kamboj M, Lewis JD, Rincon SL, Reyes J, Carvajal LP, Panesso D, Sifri CD, Zervos MJ, Pamer EG, Tran TT, Adachi J, Munita JM, Hasbun R, Arias CA (2016) Influence of minimum inhibitory concentration in clinical outcomes of enterococcus faecium bacteremia treated with daptomycin: is it time to change the breakpoint? Clin Infect Dis 62(12):1514–1520

    Article  CAS  Google Scholar 

  12. Beganovic M, Luther MK, Rice LB, Arias CA, Rybak MJ, LaPlante KL (2018) A review of combination antimicrobial therapy for Enterococcus faecalis bloodstream infections and infective endocarditis. Clin Infect Dis 67(2):303–309

    Article  CAS  Google Scholar 

  13. Baddour M, Wilson WR, Bayer AS, Fowler VG, Tleyjeh IM, Rybak MJ, Barsic B, Lockhart PB, Gewitz MH, Levison ME, Bolger AF, Steckelberg JM, Baltimore RS, Fink AM, O’Gara P, Tauberti KA, on behalf of the American Heart Association Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young, Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and Stroke Council (2015) Infective endocarditis in adults: diagnosis, antimicrobial therapy, and management of complications. Circulation 132(15):1435–1486

    Article  CAS  Google Scholar 

Download references

Funding

Partially supported by CIBERES, Instituto de Salud Carlos III (CB06-06-036), Madrid, Spain.

Author information

Authors and Affiliations

  1. Centro de Investigacion Biomedica en Red de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, Barcelona, Spain

    Jordi Rello

  2. Clinical Research/Epidemiology In Pneumonia and Sepsis (CRIPS), Vall d’Hebron Institut of Research (VHIR), Barcelona, Spain

    Jordi Rello

  3. Clinical Research in ICU, Anesthesiology Department, CHU Nîmes, University Montpellier, Nîmes, France

    Jordi Rello

  4. Clinical Infectious Diseases, Department of System Medicine, Tor Vergata University, Rome, Italy

    Laura Campogiani

  5. Department of Microbiology, Kasturba Medical College, Manipal Academy of Higher Education, Manipal, India

    Vandana Kalwaje Eshwara

Authors
  1. Jordi Rello
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Laura Campogiani
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Vandana Kalwaje Eshwara
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Laura Campogiani.

Ethics declarations

Conflicts of interest

The authors declare that they have no conflicts of interest: JR, LC, VKE.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOCX 17 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Rello, J., Campogiani, L. & Eshwara, V.K. Understanding resistance in enterococcal infections. Intensive Care Med 46, 353–356 (2020). https://doi.org/10.1007/s00134-019-05875-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00134-019-05875-9

Search

Navigation